
PRA Health Sciences, Inc. PRAH
PRA Health Sciences, Inc. Betriebsaufwand 2011-2026 | PRAH
Betriebsaufwand Jährlich PRA Health Sciences, Inc.
| 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|
| 585 M | 510 M | 484 M | 400 M | 339 M | 324 M | 351 M | - | 191 M | - |
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 585 M | 191 M | 398 M |
Betriebsaufwand anderer Aktien in der Diagnostik & Forschung
| Name | Betriebsaufwand | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
|
Centogene N.V.
CNTG
|
58 M | - | -6.23 % | $ 30.6 M | ||
|
Agilent Technologies
A
|
1.99 B | $ 121.23 | 2.52 % | $ 36.9 B | ||
|
Burning Rock Biotech Limited
BNR
|
726 M | $ 21.5 | -4.47 % | $ 231 M | ||
|
Accelerate Diagnostics
AXDX
|
77.2 M | - | -61.36 % | $ 2.46 M | ||
|
Aspira Women's Health
AWH
|
13.8 M | - | -6.19 % | $ 10.5 M | ||
|
Biocept
BIOC
|
21.6 M | - | -13.05 % | $ 7.29 M | ||
|
Check-Cap Ltd.
CHEK
|
14.1 M | - | - | $ 9.42 M | ||
|
Chembio Diagnostics
CEMI
|
28.5 M | - | 0.22 % | $ 16.8 M | ||
|
Myriad Genetics
MYGN
|
964 M | $ 5.15 | 3.0 % | $ 477 M | ||
|
CareDx, Inc
CDNA
|
411 M | $ 21.87 | -2.48 % | $ 1.17 B | ||
|
Oxford Immunotec Global PLC
OXFD
|
59.4 M | - | - | $ 562 M | ||
|
NeoGenomics
NEO
|
430 M | $ 8.35 | 2.33 % | $ 1.07 B | ||
|
Neogen Corporation
NEOG
|
1.48 B | $ 9.56 | 3.46 % | $ 2.07 B | ||
|
DermTech
DMTK
|
104 M | - | -11.32 % | $ 2.94 M | ||
|
Akumin
AKU
|
778 M | - | -17.87 % | $ 25.9 M | ||
|
Koninklijke Philips N.V.
PHG
|
7.12 B | $ 29.7 | 3.66 % | $ 20 B | ||
|
Enzo Biochem
ENZ
|
47.4 M | - | -8.98 % | $ 14.8 K | ||
|
Co-Diagnostics
CODX
|
50.6 M | $ 1.55 | 6.12 % | $ 2.06 M | ||
|
Precipio
PRPO
|
11.9 M | $ 28.81 | 0.84 % | $ 46.2 M | ||
|
Exact Sciences Corporation
EXAS
|
2.47 B | - | - | $ 19.8 B | ||
|
Castle Biosciences
CSTL
|
59.5 M | $ 25.18 | 2.77 % | $ 699 M | ||
|
Senseonics Holdings
SENS
|
61.8 M | $ 6.81 | 0.59 % | $ 284 M | ||
|
Global Cord Blood Corporation
CO
|
451 M | - | - | $ 399 M | ||
|
Fluidigm Corporation
FLDM
|
134 M | - | 1.08 % | $ 308 M | ||
|
Soleno Therapeutics
SLNO
|
181 M | $ 52.66 | 0.16 % | $ 2.68 B | ||
|
Genetic Technologies Limited
GENE
|
5.91 M | - | - | $ 7.1 B | ||
|
Genetron Holdings Limited
GTH
|
983 M | - | 0.12 % | $ 80.1 M | ||
|
Charles River Laboratories International
CRL
|
607 M | $ 184.64 | 4.35 % | $ 9.15 B | ||
|
Neuronetics
STIM
|
104 M | $ 1.43 | 1.79 % | $ 94.3 M | ||
|
Danaher Corporation
DHR
|
6.71 B | $ 195.67 | 0.97 % | $ 139 B | ||
|
Interpace Biosciences
IDXG
|
20 M | $ 2.0 | -9.09 % | $ 8.85 M | ||
|
Heska Corporation
HSKA
|
131 M | - | - | $ 1.31 B | ||
|
Thermo Fisher Scientific
TMO
|
7.15 B | $ 526.53 | 2.05 % | $ 199 B | ||
|
HTG Molecular Diagnostics
HTGM
|
24.1 M | - | -20.0 % | $ 1.06 M | ||
|
Trinity Biotech plc
TRIB
|
28.3 M | $ 0.71 | 2.05 % | $ 61.9 M | ||
|
Medpace Holdings
MEDP
|
118 M | $ 523.07 | 1.44 % | $ 15.1 B | ||
|
Illumina
ILMN
|
3.69 B | $ 133.5 | 0.59 % | $ 21.2 B | ||
|
Twist Bioscience Corporation
TWST
|
116 M | $ 60.73 | 7.99 % | $ 3.63 B | ||
|
Fulgent Genetics
FLGT
|
181 M | $ 16.28 | 0.93 % | $ 492 M | ||
|
Guardant Health
GH
|
226 M | $ 91.13 | 6.34 % | $ 11.4 B | ||
|
QIAGEN N.V.
QGEN
|
821 M | - | - | $ 10.6 B | ||
|
Anixa Biosciences
ANIX
|
9.98 M | $ 2.82 | -0.35 % | $ 91.5 K | ||
|
Biomerica
BMRA
|
5.64 M | $ 2.17 | -1.14 % | $ 4.98 M | ||
|
Motus GI Holdings
MOTS
|
18.6 M | - | -34.28 % | $ 263 K | ||
|
ICON Public Limited Company
ICLR
|
408 M | $ 118.96 | 2.92 % | $ 9.81 B | ||
|
Laboratory Corporation of America Holdings
LH
|
1.87 B | $ 272.18 | 2.12 % | $ 22.6 B | ||
|
Waters Corporation
WAT
|
687 M | $ 328.11 | 2.85 % | $ 19.5 B | ||
|
Celcuity
CELC
|
172 M | $ 122.17 | -2.46 % | $ 5.71 B | ||
|
Lantheus Holdings
LNTH
|
123 M | $ 83.39 | -0.63 % | $ 5.63 B |